Target discovery can start with intact tumor cells rather than a nominated antigen. This AML workflow pairs whole-cell phage display with CRISPR knockout deconvolution to identify both binder and target. #UbiTiter
Antigen-barcoded single-cell sequencing has changed conventional antibody discovery. nbLIBRA-seq adapts it to camelid heavy-chain antibodies, linking VHH sequence to antigen specificity in the same experiment. #UbiTiter
An ADC can lose potency while routine DAR, purity, and electrophoresis assays remain within specification. SYD1875 exposed a linker-payload reaction that standard release tests missed. #UbiTiter
A model can look strong while learning project identity rather than developability. This VHH study uses group-aware validation to test whether non-specific-binding models generalize beyond close relatives. #UbiTiter
A pharmacometrics agent should not regenerate numerical analysis on every run. PMxAgent routes execution through validated R tools exposed over MCP. #UbiTiter
